Detalhe da pesquisa
1.
Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical Trial.
Alzheimer Dis Assoc Disord
; 30(1): 1-7, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26885819
2.
Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab.
Alzheimers Dement
; 7(4): 396-401, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21784350
3.
Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's disease.
Alzheimers Dement (N Y)
; 5: 328-337, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31388559
4.
Multislice brain myelin water fractions at 3T in multiple sclerosis.
J Neuroimaging
; 17(2): 156-63, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17441837
5.
Measurement of in vivo multi-component T2 relaxation times for brain tissue using multi-slice T2 prep at 1.5 and 3 T.
Magn Reson Imaging
; 24(1): 33-43, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16410176
6.
Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease.
Alzheimers Dement (Amst)
; 2: 75-85, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27239538
7.
Deformation-based atrophy computation by surface propagation and its application to Alzheimer's disease.
J Med Imaging (Bellingham)
; 3(1): 014005, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27014717
8.
Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
Arch Neurol
; 61(7): 1081-6, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15262739
9.
3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
Int J Radiat Oncol Biol Phys
; 59(1): 126-37, 2004 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15093908
10.
Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis.
JAMA Neurol
; 71(7): 840-7, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24839987
11.
Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study).
Arch Med Sci
; 7(1): 102-11, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22291741
12.
Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema.
J Magn Reson Imaging
; 21(6): 701-8, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15906339
13.
Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
NMR Biomed
; 17(1): 10-20, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15011246
14.
Directional diffusion in relapsing-remitting multiple sclerosis: a possible in vivo signature of Wallerian degeneration.
J Magn Reson Imaging
; 18(4): 420-6, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14508778
15.
Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume.
J Magn Reson Imaging
; 19(5): 546-54, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15112303
16.
Dissociating perceptual and conceptual implicit memory in multiple sclerosis patients.
Brain Cogn
; 50(1): 51-61, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12372351